Jenny Barnett is the founder and CEO of Monument Therapeutics, building precision medicine for psychiatry and neurology.The medicines currently used to treat psychiatric and neurological conditions are often ineffective. Antidepressants taken by 16.7% and 14.2% of the US (CDC-2020) and UK populations (NHS-2021), respectively have been found to improve symptoms in only 20% of cases (IQWIG-2006). Jenny is on a mission to bring precision to the brain.
